Company: BIAF
Filing Date: 2025-06-02
Form Type: DEF 14A
Source: 0001641172-25-013280
Chunk: 24

Company: bioAffinity Technologies, Inc.
Filing Date: 2025-06-02
Form: DEF 14A
Chunk 24
---
 Exchange Act, whether made before or after the date        
 hereof and irrespective of any general incorporation language in any such filing.           |
| (2) | Stuart                                                                                      
 Diamond has advised us that he will not stand for re-election at the Annual Meeting. Peter  
 Knight is not a current member of the Audit Committee, but the Board has appointed him as   
 a member and Chairman of the Audit Committee effective as of the conclusion of the Annual   
 Meeting.                                                                                    |

| 15 |

<div align='center'>PROPOSAL NO. 3

APPROVAL OF THE REVERSE STOCK SPLIT</div>

The Board of Directors has adopted a
resolution setting forth a proposed amendment to our Certificate of Incorporation to effect a reverse stock split of the issued and outstanding
shares of Common Stock, a copy of which is set forth in the certificate of amendment attached to this Proxy Statement as Appendix A, declared such amendment advisable, and is recommending that our stockholders approve such proposed amendment. Such amendment will
be effected after stockholder approval thereof only in the event the Board still deems it advisable. Holders of our Common Stock are
being asked to approve the proposal that Section 4 of our Certificate of Incorporation be amended to effect a reverse stock split of
the Common Stock at a ratio in the range of one (1) share of Common Stock for every two (2) shares of Common Stock to one (1) share of
Common Stock for every one hundred (100) shares of Common Stock. If the Reverse Stock Split is approved by our stockholders and if a
certificate of amendment is filed with the Secretary of State of the State of Delaware, the certificate of amendment to our Certificate
of Incorporation will affect the Reverse Stock Split by reducing the outstanding number of shares of Common Stock. If the Board
of Directors does not implement an approved Reverse Stock Split prior to the one-year anniversary of this meeting, this vote will be
of no further force and effect, and the Board will again seek stockholder approval before implementing any reverse stock split
after that time. The Board of Directors may abandon the proposed amendment to effect the Reverse Stock Split at any time prior to its
effectiveness, whether before or after stockholder approval thereof.

As of the Record Date, the Company had
28,459,541 shares of Common Stock outstanding. For purposes of illustration, if the Reverse Stock Split is effected at a ratio
of 1-for-10, the number of issued and outstanding shares of Common Stock after the Reverse